ICD-10 Code B46.0 | Pulmonary mucormycosis Symptoms, Diagnosis, Billing

Pulmonary mucormycosis is a severe fungal infection caused by molds of the Mucorales order, primarily affecting immunocompromised individuals. It is clinically significant due to its rapid progression and high mortality rate if not promptly diagnosed and treated. The ICD-10 Code B46.0 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this critical condition.

What is ICD-10 Code B46.0 for Pulmonary mucormycosis?

ICD-10 Code B46.0 represents Pulmonary mucormycosis, a life-threatening fungal infection primarily affecting the lungs. It is often associated with underlying conditions such as diabetes mellitus or immunosuppression. This code should be used in clinical documentation and billing when diagnosing patients with confirmed or suspected pulmonary mucormycosis to ensure appropriate treatment and reimbursement.

ICD-10 Code B46.0 – Clinical Definition and Explanation of Pulmonary mucormycosis

Pulmonary mucormycosis is caused by the inhalation of spores from Mucorales fungi, leading to severe lung infections, particularly in immunocompromised patients. The condition can progress rapidly, necessitating immediate medical intervention to prevent serious complications or death.

Key Clinical Features:

• Rapid onset of respiratory symptoms such as cough and dyspnea.
• Hemoptysis and chest pain may occur in advanced cases.
• Imaging may reveal nodules, cavitary lesions, or consolidations.
• Commonly seen in patients with uncontrolled diabetes or those on immunosuppressive therapy.

ICD-10 Code B46.0 for Pulmonary mucormycosis – SOAP Notes & Clinical Use

ICD-10 Code B46.0 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of pulmonary mucormycosis. It plays a crucial role in both acute and chronic care settings, ensuring that symptoms, diagnostic findings, and therapeutic interventions are accurately recorded.

What Does ICD-10 Code B46.0 for Pulmonary mucormycosis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B46.0 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of pulmonary mucormycosis. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code B46.0 – Pulmonary mucormycosis

Pulmonary mucormycosis requires urgent medical attention and often hospitalization for effective management.

Antibiotic Therapy:

• First-line treatment includes amphotericin B, typically administered for 4-6 weeks.
• Posaconazole may be used as an alternative in certain cases.
• Isavuconazole is also an option for patients unable to tolerate amphotericin B.

Supportive Care:

• Oxygen therapy to manage hypoxemia.
• Fluid management and electrolyte monitoring.
• Surgical intervention may be necessary for necrotic tissue removal.

Infection Control:

• Implement standard precautions to prevent transmission.
• Isolate patients with confirmed mucormycosis in healthcare settings.
• Educate staff on the importance of hand hygiene and environmental controls.

How to Document Symptoms of Pulmonary mucormycosis (ICD-10 B46.0) in SOAP Notes

Subjective:

• Patient reports a persistent cough with hemoptysis.
• History of recent respiratory infections and fever.
• Known history of diabetes mellitus and recent immunosuppressive therapy.
• Complaints of chest pain and difficulty breathing.

Objective:

• Auscultation reveals bilateral crackles and wheezing.
• Respiratory rate of 24 breaths per minute.
• Oxygen saturation at 88% on room air.
• Chest X-ray shows cavitary lesions in the right lung.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Pulmonary mucormycosis (ICD-10 Code B46.0)

Assessment:

• Diagnosis: Pulmonary mucormycosis, severe.
• ICD-10 Code: B46.0.
• Contributing factors: Uncontrolled diabetes and recent immunosuppression.
• Consider differential diagnoses such as bacterial pneumonia or other fungal infections.

Plan:

• Initiate amphotericin B therapy immediately.
• Monitor blood glucose levels closely and adjust insulin as needed.
• Educate the patient on the importance of adherence to treatment and follow-up appointments.
• Schedule a follow-up CT scan to assess treatment response.

Treatment & Plan Section for ICD-10 Code B46.0 – Pulmonary mucormycosis

• Administer antifungal therapy as per guidelines.
• Implement strict glucose control in diabetic patients.
• Provide education on recognizing symptoms of worsening respiratory distress.
• Arrange for regular follow-up to monitor treatment efficacy and adjust as necessary.

Using ICD-10 Code B46.0 for Pulmonary mucormycosis in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings in the Subjective (S) and Objective (O) sections.
• Use the code in conjunction with appropriate CPT codes for antifungal therapy and diagnostic imaging.
• Document all treatment plans and patient education efforts to support billing.
• Align treatment plans with clinical guidelines to justify the use of ICD-10 Code B46.0.

Related ICD-10 Codes Often Used with Pulmonary mucormycosis

• B46.1 – Rhinocerebral mucormycosis
• B46.2 – Cutaneous mucormycosis
• B46.3 – Gastrointestinal mucormycosis
• B46.4 – Disseminated mucormycosis

ICD-10 Code B46.0 in Medical Billing and Insurance for Pulmonary mucormycosis

ICD-10 Code B46.0 is critical for billing in hospital, emergency room, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings and treatment plans to support the claim.
• Use the code in appropriate settings, such as inpatient admissions or outpatient visits for follow-up.
• Ensure that all chart elements, including patient history and treatment rationale, are clearly outlined.

Common CPT Pairings: